Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Large-scale testing (Phase 3)Study completedNCT01773070
What this trial is testing

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Who this might be right for
Hepatitis C
AbbVie (prior sponsor, Abbott) 478
Not applicableStudy completedNCT03343925
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 140
Not applicableStudy completedNCT03200171
What this trial is testing

Effect of DAAs on Behavior of HCC in HCV Patients

Who this might be right for
Carcinoma, HepatocellularHepatitis C
Al-Azhar University 300
Not applicableEnded earlyNCT01168856
What this trial is testing

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 734
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Testing effectiveness (Phase 2)Study completedNCT01609933
What this trial is testing

Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study

Who this might be right for
Chronic Hepatitis C
AbbVie (prior sponsor, Abbott) 32
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Post-approval studies (Phase 4)Study completedNCT02734173
What this trial is testing

Pilot HCV Direct Acting Antiviral Therapy and Metabolism

Who this might be right for
Hepatitis C
Ottawa Hospital Research Institute 24
Post-approval studies (Phase 4)WithdrawnNCT02292966
What this trial is testing

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism

Who this might be right for
Hepatitis C, Chronic
Kirby Institute
Post-approval studies (Phase 4)Study completedNCT01743521
What this trial is testing

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 14
Not applicableStudy completedNCT04047680
What this trial is testing

EGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

Who this might be right for
Hepatitis CRenal DiseaseViral Hepatitis C
National Taiwan University Hospital 441
Not applicableEnded earlyNCT01721265
What this trial is testing

3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 145
Not applicableStudy completedNCT03197155
What this trial is testing

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaHepatitis CDirect Acting Antivirals
Hospices Civils de Lyon 68
Early research (Phase 1)Study completedNCT01627717
What this trial is testing

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

Who this might be right for
Healthy
Centre hospitalier de l'Université de Montréal (CHUM) 11
Large-scale testing (Phase 3)Study completedNCT02446717
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV+1 more
AbbVie 141
Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT01353248
What this trial is testing

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 141
Next Page